Phospho-NFKB2 (Ser872) Antibody

What is the specificity of Phospho-NFKB2 (Ser872) Antibody?

Phospho-NFKB2 (Ser872) antibody specifically detects endogenous levels of NF-kappa-B p100 protein only when phosphorylated at serine 872. This high specificity is critical for studying the non-canonical NF-κB pathway. Most commercially available antibodies are generated using synthetic peptides derived from human NF-kappaB p100 around the phosphorylation site of Ser872 (typically amino acids 838-887) . The antibody has been validated to react with both human and mouse samples, making it suitable for comparative studies across these species . This specificity allows researchers to distinguish between phosphorylated and non-phosphorylated forms of the protein, which is essential for studying signaling dynamics and post-translational regulation mechanisms.

What are the primary applications for Phospho-NFKB2 (Ser872) Antibody?

Phospho-NFKB2 (Ser872) antibodies are primarily used in Western Blot (WB) and ELISA applications . For Western blotting, these antibodies typically detect a band of approximately 96-100 kDa corresponding to the phosphorylated p100 protein . The recommended dilution ranges are typically 1:500-1:2000 for Western blotting and 1:10000-1:20000 for ELISA applications . These antibodies are strictly for research use only (RUO) and should not be used in diagnostic or therapeutic applications . While immunocytochemistry has been suggested as a potential application for some versions of the antibody, extensive validation is required before implementing this technique in research protocols .

What is the functional significance of NF-κB2 phosphorylation at Ser872?

Phosphorylation of NF-κB2 p100 at Ser872 plays a critical role in the non-canonical NF-κB signaling pathway. In this pathway, the MAP3K14-activated CHUK/IKKA homodimer phosphorylates NFKB2/p100 (associated with RelB), inducing its proteolytic processing to NFKB2/p52 and the formation of NF-kappa-B RelB-p52 complexes . This phosphorylation is part of a regulatory mechanism controlling the processing of p100 to p52, which subsequently affects gene expression related to immune responses and acute phase reactions . The importance of this phosphorylation event has been demonstrated in multiple cellular processes, including inflammation, immunity, differentiation, cell growth, tumorigenesis, and apoptosis . Recent research has also implicated NF-κB2 in regulating the circadian clock through interactions with the CLOCK-BMAL1 heterodimer .

How should Phospho-NFKB2 (Ser872) Antibody be stored and handled?

For optimal stability and performance, Phospho-NFKB2 (Ser872) antibodies should be stored at -20°C for up to one year from the date of receipt . Most commercially available antibodies are formulated as liquids in PBS containing 50% glycerol, 0.5% BSA, and 0.02% sodium azide with a pH of approximately 7.4 . This formulation helps maintain antibody stability during storage. It is crucial to avoid repeated freeze-thaw cycles, as these can lead to protein denaturation and loss of antibody activity . For long-term storage, it is recommended to aliquot the antibody into smaller volumes upon receipt to minimize freeze-thaw cycles . When handling the antibody, always use clean pipettes and tubes to prevent contamination, and wear appropriate personal protective equipment due to the presence of sodium azide in the formulation.

How can I optimize Western blot protocols for Phospho-NFKB2 (Ser872) Antibody?

Optimizing Western blot protocols for phospho-specific antibodies requires careful attention to several key parameters. First, ensure complete preservation of phosphorylation status by using phosphatase inhibitors (such as sodium fluoride, sodium orthovanadate, and β-glycerophosphate) in all lysis and sample preparation buffers. Sample preparation should be performed at 4°C to minimize dephosphorylation. For protein separation, 6-8% SDS-PAGE gels are recommended for resolving the ~100 kDa p100 protein effectively . Transfer conditions may need optimization; semi-dry transfers at lower voltage for longer times often improve the transfer of larger proteins. For blocking, 5% BSA in TBST is preferable to milk, as milk contains phosphatases that may reduce signal intensity. Antibody dilutions should be tested empirically, starting with the manufacturer's recommendation (typically 1:500-1:2000) . Primary antibody incubation at 4°C overnight generally yields better results than shorter incubations at room temperature. Include appropriate positive controls (cells treated with non-canonical NF-κB pathway activators) and negative controls (phosphatase-treated samples) to validate specificity.

What are the best experimental models for studying NF-κB2 phosphorylation at Ser872?

Several experimental models have proven valuable for studying NF-κB2 phosphorylation at Ser872. Cell culture models include B lymphocytes, T lymphocytes, and cell lines derived from lymphomas, which typically show detectable levels of NF-κB2 expression and phosphorylation . Mouse models carrying specific mutations in the Nfkb2 gene, such as the D865G mutation (orthologous to human variants), provide valuable insights into phosphorylation-dependent regulation of NF-κB2 activity in vivo . The Nfkb2D865G/D865G genotype shows resistance to p100 degradation, suggesting that this mutation affects phosphorylation-dependent processing . For studying pathological conditions, B-cell non-Hodgkin lymphoma cell lines with chromosomal aberrations involving NFKB2 (such as translocation t(10;14)(q24;q32) with IGHA1) can be particularly informative . When selecting an experimental model, consider the endogenous expression levels of NF-κB2, the presence of other components of the non-canonical pathway, and the ability to respond to relevant stimuli.

How can I distinguish between phosphorylation at Ser872 and other phosphorylation sites on NF-κB2?

Distinguishing between different phosphorylation sites on NF-κB2 requires a multi-faceted approach. First, use antibodies with confirmed specificity for distinct phosphorylation sites, such as Ser866/870 versus Ser872 . Perform peptide competition assays using phospho-peptides corresponding to different phosphorylation sites to confirm antibody specificity. Site-directed mutagenesis (creating S872A, S866A, S870A mutants) can help determine the relative importance of each phosphorylation site in functional assays. Phospho-proteomic analysis using mass spectrometry provides comprehensive identification and quantification of all phosphorylation sites simultaneously. Time-course experiments following stimulation can reveal the temporal dynamics of phosphorylation at different sites. Kinase inhibitor studies targeting IKKα (which phosphorylates multiple sites on p100) can help determine which phosphorylation events are interdependent. When analyzing experimental data, be aware that antibodies against Ser866/870 may sometimes cross-react with phosphorylated Ser872 due to the proximity of these residues in the protein sequence .

What cell stimulation conditions promote NF-κB2 phosphorylation at Ser872?

NF-κB2 phosphorylation at Ser872 is primarily induced through activation of the non-canonical NF-κB pathway. The most effective stimuli include lymphotoxin β receptor (LTβR) ligands, B-cell activating factor (BAFF), CD40 ligand, and receptor activator of nuclear factor kappa-Β ligand (RANKL) . The timing of stimulation is critical - non-canonical pathway activation typically requires longer stimulation periods (6-24 hours) compared to the canonical pathway. Cell type-specific responses should be considered; for instance, B cells respond strongly to BAFF and CD40L, while epithelial cells may respond better to LTβR ligands. Important experimental controls include time-course analysis to capture both early and late phosphorylation events, dose-response studies to determine optimal ligand concentrations, and pathway inhibitors (such as IKKα inhibitors) to confirm specificity. Preliminary experiments to establish baseline phosphorylation levels in your specific cell system are essential, as constitutive phosphorylation may occur in some cancer cell lines or inflammatory conditions .

How do NFKB2 mutations affect Ser872 phosphorylation and associated pathologies?

Mutations affecting the phosphorylation sites in the C-terminal region of NFKB2 can significantly disrupt the normal processing of p100 to p52, leading to dysregulation of the non-canonical NF-κB pathway. The Nfkb2D865G mutation (orthologous to human variants) results in increased abundance of p100 and decreased p52, suggesting resistance to degradation . This pattern of altered p100/p52 ratio is also observed in known p100 degron mutations in humans . Functionally, these mutations can affect lymphocyte development and selection. For example, in mice with Nfkb2+/D865G genotype combined with BCL2-transgene expression, there are alterations in thymocyte selection processes, affecting the frequencies of strongly TCR-signaled Helios+CCR7- cells and weakly TCR-signaled Helios-CCR7+ cells . Clinically relevant mutations in NFKB2 have been associated with B-cell non-Hodgkin lymphoma (particularly with translocation t(10;14)(q24;q32) with IGHA1) and cutaneous T-cell leukemia, highlighting the pathological significance of disrupted NF-κB2 processing .

What are common issues when working with Phospho-NFKB2 (Ser872) Antibody and their solutions?

When working with Phospho-NFKB2 (Ser872) antibodies, several common technical issues may arise. One frequent problem is weak or absent signal in Western blots, which may be addressed by: (1) ensuring complete phosphatase inhibition during sample preparation; (2) increasing protein loading amounts (typically 20-50 μg is recommended); (3) optimizing antibody concentration; or (4) using more sensitive detection methods like enhanced chemiluminescence. High background is another common issue, typically resolved by increasing blocking time, using 5% BSA instead of milk for blocking and antibody dilution, increasing wash times, or decreasing antibody concentration. Non-specific bands can appear due to partial degradation of p100 or cross-reactivity with other phosphorylated proteins. In such cases, include appropriate controls (phosphatase-treated samples, NFKB2 knockdown cells) and consider using gradient gels for better resolution. Variability between experiments often stems from inconsistent stimulation conditions or sample handling; standardize these protocols and include internal controls for normalization. For poor reproducibility, prepare larger batches of samples when possible and maintain consistent experimental conditions.

How can I quantify and interpret changes in NF-κB2 Ser872 phosphorylation?

Accurate quantification and interpretation of NF-κB2 Ser872 phosphorylation require careful experimental design and data analysis. For Western blot quantification, always normalize phospho-NFKB2 signal to total NFKB2 protein levels to account for expression variations. Use digital image analysis software (ImageJ, etc.) for densitometric quantification, ensuring signals are within the linear range of detection . When analyzing ELISA data, generate standard curves for each experiment and ensure samples fall within the linear range of detection. Time-course experiments are essential for understanding the dynamics of phosphorylation events; non-canonical NF-κB signaling typically shows delayed and sustained activation compared to canonical pathways. When interpreting changes in phosphorylation, consider the ratio of p100 to p52, as this reflects the processing efficiency. In disease models, increased p100 accumulation with decreased p52 may indicate impaired processing due to mutations affecting phosphorylation sites . Statistical analysis should include multiple biological replicates (minimum n=3) and appropriate statistical tests based on data distribution. Remember that phosphorylation is just one aspect of pathway regulation; complementary assays measuring nuclear translocation or DNA binding activity provide a more complete picture of NF-κB2 activation.

What complementary techniques should be used alongside Phospho-NFKB2 (Ser872) Antibody analysis?

To gain a comprehensive understanding of NF-κB2 phosphorylation and function, several complementary techniques should be employed alongside Phospho-NFKB2 (Ser872) antibody analysis. Immunoprecipitation followed by Western blotting can enrich for phosphorylated proteins and reveal interaction partners . Chromatin immunoprecipitation (ChIP) assays can determine if p52 (processed from phosphorylated p100) is bound to specific DNA sequences, providing functional insights. Reporter gene assays using NF-κB responsive elements can measure transcriptional activity downstream of p100 processing. Confocal microscopy with phospho-specific antibodies can reveal subcellular localization changes following phosphorylation. CRISPR/Cas9-mediated genome editing to create specific mutations (S872A) helps establish the functional significance of this phosphorylation site. Phospho-proteomics using mass spectrometry can identify all phosphorylation sites on NF-κB2 simultaneously and quantify their relative abundance. RNA-seq analysis of cells with wild-type versus mutant NFKB2 can reveal the impact of phosphorylation on global gene expression patterns. Flow cytometry can be used to measure phospho-protein levels at the single-cell level, revealing population heterogeneity in response to stimuli .

How do post-translational modifications interact with Ser872 phosphorylation to regulate NF-κB2 function?

Ser872 phosphorylation works in concert with multiple post-translational modifications to regulate NF-κB2 processing and function. Phosphorylation at Ser866 and Ser870 often precedes or occurs simultaneously with Ser872 phosphorylation, creating a phosphorylation cluster that facilitates recognition by the SCF ubiquitin ligase complex . This sequential phosphorylation is critical for the ubiquitination of p100, which targets it for partial proteasomal degradation to generate p52. Experimental approaches to study these interactions include: (1) using phospho-mimetic mutations (S→D or S→E) to simulate constitutive phosphorylation; (2) employing proximity ligation assays to detect interactions between phosphorylated NF-κB2 and components of the ubiquitin machinery; (3) performing in vitro kinase assays with purified IKKα to establish phosphorylation sequence; and (4) using proteasome inhibitors to accumulate ubiquitinated intermediates for analysis. Notably, mutations that prevent phosphorylation at one site can affect phosphorylation at neighboring sites, creating complex regulatory networks. The relative importance of Ser872 versus Ser866/870 phosphorylation may vary depending on cell type and stimulus, necessitating comprehensive analysis in specific experimental contexts .

How can Phospho-NFKB2 (Ser872) Antibody be used to study disease mechanisms?

Phospho-NFKB2 (Ser872) antibodies offer valuable tools for investigating disease mechanisms related to NF-κB signaling dysregulation. In cancer research, these antibodies can help identify alterations in non-canonical NF-κB pathway activation in lymphomas and leukemias, where chromosomal aberrations involving NFKB2 have been reported . Researchers can compare phosphorylation patterns between normal and malignant cells to identify potential therapeutic targets. In inflammatory and autoimmune diseases, these antibodies can monitor non-canonical pathway activation in response to various stimuli, helping elucidate disease pathogenesis. Patient-derived samples can be analyzed for phosphorylation status to correlate with disease severity or therapeutic response. For immunodeficiency research, where mutations affecting NFKB2 phosphorylation have been identified, these antibodies can assess the functional consequences of such mutations . Experimental approaches include immunohistochemistry of diseased tissues, phospho-flow cytometry of patient-derived cells, and Western blot analysis of biopsy samples. When studying disease mechanisms, it's essential to include appropriate controls (age-matched healthy samples) and validate findings using multiple methodological approaches.

What emerging technologies are enhancing the study of NF-κB2 phosphorylation?

Emerging technologies are revolutionizing the study of NF-κB2 phosphorylation, offering unprecedented sensitivity and spatiotemporal resolution. Single-cell phospho-proteomics allows researchers to examine phosphorylation heterogeneity within cell populations, revealing subpopulations with distinct signaling states. CRISPR-Cas9 base editing enables precise modification of phosphorylation sites without introducing double-strand breaks, facilitating subtle regulatory studies. Phospho-specific biosensors based on FRET (Förster Resonance Energy Transfer) technology allow real-time visualization of phosphorylation events in living cells. Advanced mass spectrometry techniques, including targeted approaches like parallel reaction monitoring (PRM), provide absolute quantification of phosphorylated peptides with high sensitivity. Spatial transcriptomics combined with phospho-protein analysis can correlate phosphorylation events with gene expression patterns at the tissue level. Microfluidic platforms enable high-throughput screening of compounds affecting NF-κB2 phosphorylation with minimal sample consumption. When implementing these technologies, researchers should consider their specific research questions and the trade-offs between throughput, resolution, and technical complexity.

How does NF-κB2 Ser872 phosphorylation integrate with broader cellular signaling networks?

NF-κB2 Ser872 phosphorylation represents a node in complex cellular signaling networks, integrating inputs from multiple pathways and influencing diverse cellular responses. The non-canonical NF-κB pathway, involving Ser872 phosphorylation, cross-talks with the canonical pathway through shared regulatory components and target genes . This phosphorylation event is also connected to MAP kinase signaling, as demonstrated by changes in p38 MAPK phosphorylation occurring alongside NF-κB2 phosphorylation . AKT/PI3K signaling interacts with NF-κB2 phosphorylation, with AKT1 (phospho-Tyr474) showing coordinated regulation with NF-κB-p100 (phospho-Ser872) . Experimentally, pathway integration can be studied using phospho-protein arrays to simultaneously monitor multiple phosphorylation events, providing a systems-level view of signaling dynamics . Network analysis tools can identify key regulatory hubs and feedback mechanisms. Perturbation experiments using specific pathway inhibitors help delineate causality in complex signaling networks. When studying these interactions, consider potential temporal differences in pathway activation (immediate versus delayed responses) and cell type-specific network architectures that may affect NF-κB2 phosphorylation and its downstream consequences.

What considerations are important when comparing results across different Phospho-NFKB2 (Ser872) Antibody products?

When comparing results obtained with different Phospho-NFKB2 (Ser872) antibody products, several key considerations ensure accurate interpretation and reproducibility. First, examine the immunogen used for antibody production; most Phospho-NFKB2 (Ser872) antibodies use synthetic peptides from the region spanning amino acids 838-887, but subtle differences in peptide length or conjugation methods may affect specificity . Clonality is another important factor; monoclonal antibodies offer better batch-to-batch consistency but may recognize a single epitope, while polyclonal antibodies typically recognize multiple epitopes but may show batch variability . Host species (rabbit versus mouse) can affect applications due to differences in secondary antibody compatibility and potential cross-reactivity . Validation methods reported by manufacturers should be critically evaluated; comprehensive validation includes phosphatase treatment controls, knockout/knockdown verification, and peptide competition assays. When transitioning between antibody products, perform side-by-side comparisons using the same samples and experimental conditions. Document key antibody characteristics (catalog number, lot number, dilution) when reporting results to facilitate reproducibility. Consider using antibody validation resources like antibodypedia.com to access independent validation data beyond manufacturer claims.

What are the essential controls for validating Phospho-NFKB2 (Ser872) Antibody specificity?

Rigorous validation of Phospho-NFKB2 (Ser872) antibody specificity requires multiple complementary controls. Phosphatase treatment of cell lysates should eliminate the phospho-specific signal while preserving total NF-κB2 detection, confirming phospho-specificity. Peptide competition assays using both phosphorylated and non-phosphorylated peptides can demonstrate epitope specificity; the phosphorylated peptide should block antibody binding while the non-phosphorylated peptide should not. Genetic controls, including NFKB2 knockdown/knockout cells or cell lines expressing phospho-site mutants (S872A), provide stringent specificity tests. Stimulation controls using activators of the non-canonical pathway (BAFF, CD40L) should increase phosphorylation signal, while pathway inhibitors (IKKα inhibitors) should reduce it. Antibody cross-reactivity should be assessed using cells from different species if the antibody claims multi-species reactivity . For phospho-specific antibodies, comparing the phospho-protein to total protein ratio across experimental conditions provides an internal control for expression level changes. When publishing, include detailed descriptions of validation experiments and representative images showing both positive and negative controls to enhance reproducibility.

How should I design experiments to study the kinetics of NF-κB2 Ser872 phosphorylation?

Designing experiments to study the kinetics of NF-κB2 Ser872 phosphorylation requires careful consideration of temporal dynamics and signaling context. Begin with comprehensive time-course experiments spanning both early (0-2 hours) and late (4-24 hours) time points, as the non-canonical pathway typically shows delayed activation compared to the canonical pathway. Include multiple intermediate time points to capture the full phosphorylation profile. When selecting stimuli, use pathway-specific activators like BAFF or CD40L at concentrations determined through dose-response experiments. Synchronize cells (serum starvation for adherent cells) before stimulation to reduce baseline variability. For detection methods, consider both Western blotting for qualitative assessment and quantitative approaches like ELISA or phospho-flow cytometry for precise quantification . Always normalize phospho-specific signals to total protein levels to account for expression changes. Include pathway inhibitor controls (added at different times post-stimulation) to determine the persistence of the kinase activity responsible for phosphorylation. For advanced studies, pulse-chase experiments with transient pathway activation followed by inhibitor addition can reveal phosphorylation stability and turnover rates. Statistical analysis should include area-under-curve calculations and kinetic modeling when appropriate.

What sample preparation techniques are critical for preserving phosphorylation status?

Preserving phosphorylation status during sample preparation is crucial for accurate analysis of NF-κB2 Ser872 phosphorylation. Immediately upon collection, samples should be processed at 4°C to minimize phosphatase activity. Lysis buffers must contain comprehensive phosphatase inhibitor cocktails including sodium fluoride (50 mM), sodium orthovanadate (2 mM), β-glycerophosphate (10 mM), and commercial phosphatase inhibitor tablets . The addition of EDTA (5 mM) helps inhibit metal-dependent phosphatases. Rapid sample processing is essential; avoid prolonged storage of unprocessed samples, even on ice. Cell lysis should be performed using methods that quickly inactivate endogenous enzymes, such as addition of hot SDS sample buffer for direct Western blot analysis, or guanidinium isothiocyanate for RNA co-isolation studies. For tissue samples, snap-freezing in liquid nitrogen immediately after collection helps preserve phosphorylation status. When performing immunoprecipitation, include phosphatase inhibitors in all buffers throughout the procedure. For long-term storage, samples should be kept at -80°C with phosphatase inhibitors, and multiple freeze-thaw cycles should be strictly avoided. When analyzing phosphorylation by mass spectrometry, consider enrichment strategies such as phospho-peptide enrichment with titanium dioxide or immobilized metal affinity chromatography to enhance detection sensitivity.